|
[1]
|
Design of experiment (DOE), multiple response optimization and utilizing the desirability function in the simultaneous HPLC separation of five antihypertensive drugs
Journal of the Iranian Chemical Society,
2022
DOI:10.1007/s13738-021-02316-7
|
|
|
|
|
[2]
|
LC–MS/MS and in silico analysis of pharmaceutical impurities in a combination drug for hypertension
SEPARATION SCIENCE PLUS,
2022
DOI:10.1002/sscp.202200070
|
|
|
|
|
[3]
|
UPLC Technique in Pharmacy—An Important Tool of the Modern Analyst
Processes,
2022
DOI:10.3390/pr10122498
|
|
|
|
|
[4]
|
LC–MS/MS and in silico analysis of pharmaceutical impurities in a combination drug for hypertension
SEPARATION SCIENCE PLUS,
2022
DOI:10.1002/sscp.202200070
|
|
|
|
|
[5]
|
A Comprehensive Stability Study of Vardenafil Using Quality by Design Approach
Chromatographia,
2021
DOI:10.1007/s10337-021-04059-2
|
|
|
|
|
[6]
|
Phosphodiesterase-5 (PDE-5) Inhibitors as Emergent Environmental Contaminants: Advanced Remediation and Analytical Methods
Water,
2021
DOI:10.3390/w13202859
|
|
|
|
|
[7]
|
Smart analysis of a ternary mixture of amlodipine, hydrochlorothiazide and telmisartan by manipulation of UV spectra: Development, validation and application to formulations
Journal of Molecular Structure,
2020
DOI:10.1016/j.molstruc.2020.128095
|
|
|
|
|
[8]
|
Analytical and Bioanalytical Techniques for the Quantification of the Calcium Channel Blocker – Amlodipine: A Critical Review
Critical Reviews in Analytical Chemistry,
2020
DOI:10.1080/10408347.2020.1772036
|
|
|
|
|
[9]
|
Stability Indicating RP-HPLC Method Development and Validation for Simultaneous Quantification of 15 Organic Impurities of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide in Combined Dosage Form
Chromatographia,
2019
DOI:10.1007/s10337-019-03718-9
|
|
|
|
|
[10]
|
DAD Based Stability Indicating RP-UPLC Method for Simultaneous Determination of Olmesartan Medoxomil and Amlodipine Besylate
Pharmaceutical Chemistry Journal,
2019
DOI:10.1007/s11094-019-01933-0
|
|
|
|
|
[11]
|
Simultaneous Quantitation of Amlodipine Besylate and Olmesartan Medoxomil in Fixed-Dose Combination Tablets: HPLC-DAD Versus UHPLC-DAD
Journal of Chromatographic Science,
2018
DOI:10.1093/chromsci/bmy004
|
|
|
|
|
[12]
|
Applying green analytical chemistry for rapid analysis of drugs: Adding health to pharmaceutical industry
Arabian Journal of Chemistry,
2017
DOI:10.1016/j.arabjc.2012.12.004
|
|
|
|
|
[13]
|
Profiles of Drug Substances, Excipients and Related Methodology,
2017
DOI:10.1016/bs.podrm.2017.02.005
|
|
|
|
|
[14]
|
UV SPECTROPHOTOMETRIC ABSORPTION CORRECTION METHOD FOR SIMULTANEOUS ESTIMATION OF OLMESA RTAN MEDOXOMIL, AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE IN COMBINED TABLET DOSAGE FORM
INDIAN DRUGS,
2017
DOI:10.53879/id.54.07.10761
|
|
|
|
|
[15]
|
Novel approach for UPLC-ESI-Tandem mass spectrometric method for simultaneous determination of olmesartan medoxomil and hydrochlorothiazide in their pharmaceutical combination with kinetic studies of forced degradation
European Journal of Chemistry,
2016
DOI:10.5155/eurjchem.7.3.309-314.1450
|
|
|
|
|
[16]
|
Simultaneous quantitative analysis of olmesartan, amlodipine and hydrochlorothiazide in their combined dosage form utilizing classical and alternating least squares based chemometric methods
Acta Pharmaceutica,
2016
DOI:10.1515/acph-2016-0004
|
|
|
|
|
[17]
|
Development and Validation of highly Sensitive Stability Indicating Spectrofluorimetric Method for Determination of Amlodipine in Pharmaceutical Preparations and Human Plasma
Journal of Fluorescence,
2016
DOI:10.1007/s10895-016-1910-4
|
|
|
|
|
[18]
|
Simultaneous Determination of Telmisartan and Amlodipine in Dog Plasma by LC–MS-MS
Journal of Chromatographic Science,
2015
DOI:10.1093/chromsci/bmv078
|
|
|
|
|
[19]
|
Profiles of Drug Substances, Excipients and Related Methodology,
2014
DOI:10.1016/B978-0-12-800173-8.00009-X
|
|
|
|
|
[20]
|
Application of smart spectrophotometric methods and artificial neural network for the simultaneous quantitation of olmesartan medoxamil, amlodipine besylate and hydrochlorothiazide in their combined pharmaceutical dosage form
Chemistry Central Journal,
2013
DOI:10.1186/1752-153X-7-22
|
|
|
|